|
Hance Clarke, MD, PhD, FRCPC |
![]() SECRETARY (2020-2023)G. Allen Finley, MD FRCPC FAAP Dr. Allen Finley is a pediatric anesthesiologist who has worked for 30 years in pain research and management. He is Professor of Anesthesia, Pain Management, & Perioperative Medicine at Dalhousie University, and is cross-appointed as Professor of Psychology & Neuroscience. He also holds the inaugural Dr. Stewart Wenning Chair in Pediatric Pain Management at the IWK Health Centre in Halifax and is Director of the Centre for Pediatric Pain Research. He has published over 140 papers in peer-reviewed journals (http://tinyurl.com/gaf-cits) and has lectured widely, with more than 300 invited presentations on six continents. He started the PEDIATRIC-PAIN e-mail discussion list in 1993, bringing together pain researchers and clinicians from over 40 countries. His own research and educational projects have taken him to Jordan, Thailand, China, Brazil, and elsewhere, with a primary focus on pain service development and advocacy for improved pain care for children around the world. To facilitate that, he is co-founder and Board Chair of the ChildKind International Initiative. From 2016-2020 he served as Treasurer on the Executive of the International Association for the Study of Pain, an exciting opportunity to be part of the promotion of pain science and pain care around the world. His current research work includes collaborations with colleagues at Dalhousie, U. of Ottawa, and elsewhere, including as co-PI of the CIHR SPOR Chronic Pain Network and SKIP (Solutions for Kids in Pain – kidsinpain.ca) Hub Lead for Atlantic Canada.
|
|
Anna Taylor, PhD Dr. Anna Taylor is a Canada Research Chair in Pain and Addiction and an assistant professor in the Department of Pharmacology. She completed her doctoral degree at the McGill Pain Center in 2011, followed by postdoctoral training at the University of California, Los Angeles in the NIH-funded Opioid Research Center. Her expertise spans the fields of opioid addiction and chronic pain. Dr. Taylor’s research program engages a broad range of disciplines including pharmacology, microbiology, genetics, and animal behaviour to provide mechanistic insight into how affective circuitry contributes to pain and addiction. Her research strives to understand how chronic pain changes affective brain circuits and whether these changes alter the effects of opioids. She explores strategies to improve opioid efficacy while minimizing addiction risk. Finally, she is developing novel, non-addicting opioid agonists to treat pain without abuse liability. This research comes at a critical juncture when safe and effective chronic pain management is increasingly challenging amidst the opioid overdose epidemic. Dr. Taylor’s research has been continuously funded by the National Institutes for Health, the American Pain Society, the Natural Sciences and Engineering Research Council of Canada, the Canadian Pain Society, and the Canada Foundation for Innovation.
| Co - Chair SCIENTIFIC PROGRAM COMMITTEE Gabrielle Page Dr. Pagé is a clinical psychologist and pain researcher in the Department of Anesthesiology and Pain Medicine at the Université de Montréal. She is also a scientist at the Research Center of the Centre hospitalier du Université de Montréal. She is a Junior 1 research scholar from the Fonds de recherche du Québec en santé. She is a member of the scientific committee of the strategic initiative on low back pain and co-leads the strategic initiative on the judicious use of opioids of the Quebec Pain Research Network. Her line of research examines the bidirectional associations between stress and pain, the trajectories from acute to chronic pain, and the impact of mental and physical comorbidities on chronic pain treatment response. She has authored more than 70 peer-reviewed scientific articles and 6 book chapters. She is the recipient of the 2018 Early Career Investigator Pain Research Grant from the Canadian Pain Society.
|
| ![]() Co-Chair, Interprofessional Special Interest GroupTimothy Wideman, PhD Associate Professor, School of Physical and Occupational Therapy, McGill University Dr. Wideman is a physiotherapist and associate professor at McGill University. The overarching goal of his work as a clinician, educator and researcher has been to improve the clinical care offered to people living with persistent pain. He has aimed to cultivate a comprehensive perspective on pain throughout his training and clinical experience. He completed his entry-level physiotherapy training in 2003 and has practiced across a range of clinical settings, including homecare, private clinics and multi-disciplinary pain management programs. Driven by his interest in better understanding how psychological and neurophysiological factors relate to pain and disability, he completed his doctoral training in McGill’s experimental psychology program and focused his post-doctoral fellowship at Johns Hopkins on the clinical assessment of pain sensitization. He joined McGill faculty in 2014 and his recent work has focused on understanding pain-related suffering and working to improve entry-level pain education for physiotherapy students across Canada. Dr. Wideman has received several national awards for excellence in research and clinical education, including a New Investigator Award from CIHR, as well Knowledge Translation and Mentor Awards from the Canadian Physiotherapy Association. |
|
|
Nader Ghasemlou Nader is an Associate Professor at Queen’s University, where he leads the Pain Chronobiology & Neuroimmunology Lab (ghasemloulab.ca) and serves as Director of Translational Pain Research at the Hotel-Dieu Hospital Chronic Pain Clinic. His research team works at the intersection of neuroimmunology, pain physiology, and circadian biology. Using various animal models of tissue injury and disease, including multiple sclerosis, spinal cord injury, postoperative wounds, and neuropathic nerve injury, the team seeks to better understand the molecular, cellular, and systems responses underlying human disease. The group is particularly focused on dissecting mechanisms underlying the generation and maintenance of inflammation in the central and peripheral nervous system. All projects in the lab include bioinformatics component to identify genes/pathways regulating cell function, and patient cohort studies which provide a translational component to our work. Nader completed his PhD at McGill University and was a CIHR Banting Fellow at Harvard Medical School. He is recipient of a CPS/Pfizer Early Career Award, a Brain Canada Future Leaders in Canadian Brain Research Award, and the Canadian Anesthesiology Society’s New Investigator Award. Projects in the Pain Chronobiology & Neuroimmunology Lab are currently funded by grants from CIHR, NSERC, the MS Society of Canada, and the Craig H. Neilsen Foundation. Nader also serves on the CPS Scientific Program and Membership & Engagement Committees; is co-chair of the Knowledge Translation Committee and sits on the Executive of the CIHR-SPOR Chronic Pain Network; and is a member of the Education & Training Committee of the Multiple Sclerosis Society of Canada’s endMS Training Program. |